162 related articles for article (PubMed ID: 28888579)
21. Feasibility and Prognostic Effect of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Cytology-Proven, Node-Positive Breast Cancer.
Park S; Lee JE; Paik HJ; Ryu JM; Bae SY; Lee SK; Kim SW; Nam SJ
Clin Breast Cancer; 2017 Feb; 17(1):e19-e29. PubMed ID: 27495997
[TBL] [Abstract][Full Text] [Related]
22. [Risk of axillary recurrence after sentinel lymph node biopsy before neoadjuvant chemotherapy in breast cancer].
Tardieu A; Mesnard C; Margueritte F; Mollard J; Lacorre A; Aubard Y; Deluche E; Gauthier T
Gynecol Obstet Fertil Senol; 2018 Jun; 46(6):509-513. PubMed ID: 29776842
[TBL] [Abstract][Full Text] [Related]
23. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
[TBL] [Abstract][Full Text] [Related]
25. Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer.
Zetterlund LH; Frisell J; Zouzos A; Axelsson R; Hatschek T; de Boniface J; Celebioglu F
Breast Cancer Res Treat; 2017 May; 163(1):103-110. PubMed ID: 28224384
[TBL] [Abstract][Full Text] [Related]
26. [Axillary pathologic response after neoadjuvant chemotherapy in locally advanced breast cancer with axillary involvement].
Jiménez-Ballvé A; Serrano-Palacio A; García-Sáenz JA; Ortega Candil A; Salsidua-Arroyo O; Román-Santamaría JM; Pelayo Alarcón A; Fuentes Ferrer ME; Carreras-Delgado JL
Rev Esp Med Nucl Imagen Mol; 2015; 34(4):230-5. PubMed ID: 25743035
[TBL] [Abstract][Full Text] [Related]
27. Does the result of completion axillary lymph node dissection influence the recommendation for adjuvant treatment in sentinel lymph node-positive patients?
Sávolt A; Polgár C; Musonda P; Mátrai Z; Rényi-Vámos F; Tóth L; Kásler M; Péley G
Clin Breast Cancer; 2013 Oct; 13(5):364-70. PubMed ID: 23773380
[TBL] [Abstract][Full Text] [Related]
28. Validation of sentinel lymph node biopsy in breast cancer women N1-N2 with complete axillary response after neoadjuvant chemotherapy. Multicentre study in Tarragona.
Carrera D; de la Flor M; Galera J; Amillano K; Gomez M; Izquierdo V; Aguilar E; López S; Martínez M; Martínez S; Serra JM; Pérez M; Martin L
Rev Esp Med Nucl Imagen Mol; 2016; 35(4):221-5. PubMed ID: 26848141
[TBL] [Abstract][Full Text] [Related]
29. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA
Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
[TBL] [Abstract][Full Text] [Related]
30. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: retrospective comparative evaluation of clinically axillary lymph node positive and negative patients, including those with axillary lymph node metastases confirmed by fine needle aspiration.
Yu Y; Cui N; Li HY; Wu YM; Xu L; Fang M; Sheng Y
BMC Cancer; 2016 Oct; 16(1):808. PubMed ID: 27756234
[TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node biopsy after neoadjuvant systemic chemotherapy in patients with breast cancer: a prospective pilot trial.
Medina-Franco H; Salgado-Nesme N; Zerón-Medina-Cuairán J
Rev Invest Clin; 2008; 60(5):390-4. PubMed ID: 19227436
[TBL] [Abstract][Full Text] [Related]
32. Factors impacting the accuracy of intra-operative evaluation of sentinel lymph nodes in breast cancer.
Akay CL; Albarracin C; Torstenson T; Bassett R; Mittendorf EA; Yi M; Kuerer HM; Babiera GV; Bedrosian I; Hunt KK; Hwang RF
Breast J; 2018 Jan; 24(1):28-34. PubMed ID: 28608612
[TBL] [Abstract][Full Text] [Related]
33. Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer.
Yagata H; Yamauchi H; Tsugawa K; Hayashi N; Yoshida A; Kajiura Y; In R; Matsuda N; Nakamura S
Clin Breast Cancer; 2013 Dec; 13(6):471-7. PubMed ID: 24267732
[TBL] [Abstract][Full Text] [Related]
34. [Sentinel lymph node biopsy and neoadjuvant treatment in breast cancer].
Duraes M; Guillot E; Seror J; Pouget N; Rouzier R
Bull Cancer; 2017 Oct; 104(10):892-901. PubMed ID: 28890124
[TBL] [Abstract][Full Text] [Related]
35. Surgical management of early stage invasive breast cancer: a practice guideline.
McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
[TBL] [Abstract][Full Text] [Related]
36. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
37. Thin-section CT evaluation and pathologic correlation of therapeutic effect of neoadjuvant chemotherapy for axillary lymph nodes of clinically node-positive breast cancer patients.
Ogawa Y; Nishioka A; Nishigawa T; Kubota K; Kariya S; Yoshida S; Tanaka Y; Moriki T; Tochika N
Oncol Rep; 2003; 10(4):985-9. PubMed ID: 12792757
[TBL] [Abstract][Full Text] [Related]
38. Axillary ultrasound examination is useful for selecting patients optimally suited for sentinel lymph node biopsy after primary systemic chemotherapy.
Shigekawa T; Sugitani I; Takeuchi H; Misumi M; Nakamiya N; Sugiyama M; Sano H; Matsuura K; Takahashi T; Fujiuchi N; Osaki A; Saeki T
Am J Surg; 2012 Oct; 204(4):487-93. PubMed ID: 22483167
[TBL] [Abstract][Full Text] [Related]
39. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma.
Cipolla C; Graceffa G; La Mendola R; Fricano S; Fricano M; Vieni S
Ann Ital Chir; 2015; 86():497-502. PubMed ID: 26898168
[TBL] [Abstract][Full Text] [Related]
40. Repeat sentinel lymph node biopsy in patients with ipsilateral recurrent breast cancer after breast-conserving therapy and negative sentinel lymph node biopsy: a prospective study.
Folli S; Falco G; Mingozzi M; Buggi F; Curcio A; Ferrari G; Taffurelli M; Regolo L; Nanni O
Minerva Chir; 2016 Apr; 71(2):73-9. PubMed ID: 26207566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
